2011
DOI: 10.4103/1742-6413.76379
|View full text |Cite
|
Sign up to set email alerts
|

p16INK4a immunocytochemistry on cell blocks as an adjunct to cervical cytology: Potential reflex testing on specially prepared cell blocks from residual liquid-based cytology specimens

Abstract: Background:p16 INK4a (p16) is a well-recognized surrogate molecular marker for human papilloma virus (HPV) related squamous dysplasia. Our hypothesis is that the invasive interventions and related morbidities could be avoided by objective stratification of positive cytologic interpretations by p16 immunostaining of cell block sections of cytology specimens.Materials and Methods:Nuclear immunoreactivity for p16 was evaluated in cell block sections in 133 adequate cases [20 negative for intraepithelial lesion or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 23 publications
(45 reference statements)
1
22
0
Order By: Relevance
“…Thus helping in improving diagnostic accuracy of cervical lesion. These were consistent with findings of Siddham V. B et al [57] for p16inK4a and by Sahebali s et al [58] for KI67. (Table 9,) FIG 6 There are many studies done on markers and endometrium.…”
Section: Uses Of Cell Block Aresupporting
confidence: 82%
“…Thus helping in improving diagnostic accuracy of cervical lesion. These were consistent with findings of Siddham V. B et al [57] for p16inK4a and by Sahebali s et al [58] for KI67. (Table 9,) FIG 6 There are many studies done on markers and endometrium.…”
Section: Uses Of Cell Block Aresupporting
confidence: 82%
“…Cervical cancer is the second most commonly diagnosed [15] and fifth deadliest [16] cancer in women throughout the world. In developing countries cervical cancer has a major share in cancer mortality [17]. Every year about 500,000 new cases are diagnosed and among which about 250,000 patient die.…”
Section: Cervical Cancermentioning
confidence: 99%
“…Cervical cancer is the second most commonly diagnosed [15] and fifth deadliest [16] cancer in women throughout the world. In developing countries cervical cancer has a major share in cancer mortality [17]. Every year about 5,00,000 new cases are diagnosed and among which about 2 50 000 patient die.…”
Section: Cervical Cancermentioning
confidence: 99%
“…The Papanicolaou test (Pap smear) has been the widely used method in cervical cancer screening for many decades and has showed a dramatic lowering of incidents of cervical cancer and hence in related mortality rates in many countries [17]. In taking a Pap smear, the cells of are scraped form the outer opening of the cervix for microscopic examination and to lookup for irregularities.…”
Section: Papanicolaou Testmentioning
confidence: 99%